SARS-CoV-2 testing in North Carolina: Racial, ethnic, and geographic disparities.


Journal

Health & place
ISSN: 1873-2054
Titre abrégé: Health Place
Pays: England
ID NLM: 9510067

Informations de publication

Date de publication:
05 2021
Historique:
received: 08 10 2020
revised: 07 04 2021
accepted: 09 04 2021
pubmed: 30 4 2021
medline: 22 6 2021
entrez: 29 4 2021
Statut: ppublish

Résumé

SARS-CoV-2 testing data in North Carolina during the first three months of the state's COVID-19 pandemic were analyzed to determine if there were disparities among intersecting axes of identity including race, Latinx ethnicity, age, urban-rural residence, and residence in a medically underserved area. Demographic and residential data were used to reconstruct patterns of testing metrics (including tests per capita, positive tests per capita, and test positivity rate which is an indicator of sufficient testing) across race-ethnicity groups and urban-rural populations separately. Across the entire sample, 13.1% (38,750 of 295,642) of tests were positive. Within racial-ethnic groups, 11.5% of all tests were positive among non-Latinx (NL) Whites, 22.0% for NL Blacks, and 66.5% for people of Latinx ethnicity. The test positivity rate was higher among people living in rural areas across all racial-ethnic groups. These results suggest that in the first three months of the COVID-19 pandemic, access to COVID-19 testing in North Carolina was not evenly distributed across racial-ethnic groups, especially in Latinx, NL Black and other historically marginalized populations, and further disparities existed within these groups by gender, age, urban-rural status, and residence in a medically underserved area.

Identifiants

pubmed: 33915376
pii: S1353-8292(21)00072-1
doi: 10.1016/j.healthplace.2021.102576
pmc: PMC8212571
mid: NIHMS1703078
pii:
doi:

Types de publication

Comparative Study Journal Article Research Support, N.I.H., Extramural

Langues

eng

Pagination

102576

Subventions

Organisme : NICHD NIH HHS
ID : P2C HD050924
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES010126
Pays : United States
Organisme : NIEHS NIH HHS
ID : T32 ES007018
Pays : United States
Organisme : NICHD NIH HHS
ID : T32 HD091058
Pays : United States

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Références

MMWR Morb Mortal Wkly Rep. 2020 Jul 24;69(29):960-964
pubmed: 32701938
Ann Epidemiol. 2020 Jul;47:37-44
pubmed: 32419766
MMWR Morb Mortal Wkly Rep. 2020 May 08;69(18):
pubmed: 32379731
J Prev Med Public Health. 2020 Jul;53(4):220-227
pubmed: 32752590
JAMA. 2020 Apr 14;323(14):1406-1407
pubmed: 32083643
Ann Epidemiol. 2020 Dec;52:46-53.e2
pubmed: 32711053
Du Bois Rev. 2011 Apr;8(1):115-132
pubmed: 25632292
Ann N Y Acad Sci. 2010 Feb;1186:69-101
pubmed: 20201869
MMWR Morb Mortal Wkly Rep. 2020 May 08;69(18):545-550
pubmed: 32379729
J Rural Health. 2020 Jun;36(3):446-456
pubmed: 32543751
Am J Ind Med. 2020 Sep;63(9):817-820
pubmed: 32539166
Lancet. 2020 Feb 15;395(10223):514-523
pubmed: 31986261
Am J Prev Med. 2020 Sep;59(3):326-332
pubmed: 32703702
Health Educ Behav. 2020 Aug;47(4):504-508
pubmed: 32338071
J Health Polit Policy Law. 2020 Dec 1;45(6):937-950
pubmed: 32464657
MMWR Morb Mortal Wkly Rep. 2020 Jul 17;69(28):923-929
pubmed: 32673298
Ethn Health. 2021 Jan;26(1):36-48
pubmed: 33428455
JAMA Netw Open. 2020 Jul 1;3(7):e2016933
pubmed: 32721026
Am J Ind Med. 2010 Feb;53(2):104-15
pubmed: 19816887
Int J Equity Health. 2013 Mar 11;12:18
pubmed: 23496984
Am J Public Health. 2012 Jul;102(7):1267-73
pubmed: 22594719
Lancet. 2020 Nov 7;396(10261):e81
pubmed: 33169681
Am J Epidemiol. 2020 Nov 2;189(11):1244-1253
pubmed: 32619007
Clin Infect Dis. 2020 Jul 28;71(15):825-832
pubmed: 32277759
JAMA Netw Open. 2021 Jan 4;4(1):e2034578
pubmed: 33471120
MMWR Morb Mortal Wkly Rep. 2020 Jul 10;69(27):887-892
pubmed: 32644986
J Rural Health. 2020 Sep;36(4):591-601
pubmed: 32602983
JAMA. 2020 Jun 23;323(24):2466-2467
pubmed: 32391864
Glob Epidemiol. 2020 Nov;2:100031
pubmed: 32995744
Epidemiology. 2021 Mar 1;32(2):157-161
pubmed: 33323745
Am J Prev Med. 2020 Sep;59(3):317-325
pubmed: 32703701

Auteurs

Katerina Brandt (K)

UNC Department of Geography, Chapel Hill, NC, USA; Carolina Population Center, Chapel Hill, NC, USA.

Varun Goel (V)

UNC Department of Geography, Chapel Hill, NC, USA; Carolina Population Center, Chapel Hill, NC, USA.

Corinna Keeler (C)

UNC Department of Epidemiology, Chapel Hill, NC, USA.

Griffin J Bell (GJ)

UNC Department of Epidemiology, Chapel Hill, NC, USA.

Allison E Aiello (AE)

Carolina Population Center, Chapel Hill, NC, USA; UNC Department of Epidemiology, Chapel Hill, NC, USA.

Giselle Corbie-Smith (G)

Division of Infectious Diseases, UNC School of Medicine, Chapel Hill, NC, USA.

Erica Wilson (E)

North Carolina Department of Health and Human Services, Raleigh, NC, USA.

Aaron Fleischauer (A)

North Carolina Department of Health and Human Services, Raleigh, NC, USA.

Michael Emch (M)

UNC Department of Geography, Chapel Hill, NC, USA; Carolina Population Center, Chapel Hill, NC, USA; UNC Department of Epidemiology, Chapel Hill, NC, USA. Electronic address: emch@unc.edu.

Ross M Boyce (RM)

Division of Infectious Diseases, UNC School of Medicine, Chapel Hill, NC, USA. Electronic address: roboyce@med.unc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH